Jounce Therapeutics Inc.

NASDAQ: JNCE · Real-Time Price · USD
1.88
0.00 (0.00%)
At close: May 03, 2023, 10:00 PM

Jounce Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.13 -4.59
PEG Ratio
0.02 -0.1
PS Ratio
0.70 15.49
PB Ratio
0.31 1.86
P/FCF Ratio
-1.93 -4.97
P/OCF Ratio
-1.99 -4.99
OCF/S Ratio
-0.35 -3.1
Debt / Equity Ratio
0.05 0.06
Quick Ratio
8.37 10.10
Current Ratio
8.37 10.10
Asset Turnover
0.39 0.11
Interest Coverage
n/a n/a
Return on Equity
-0.28 -0.41
Return on Assets
-0.24 -0.36
Return on Invested Capital
-0.27 -0.38
Dividend Yield
n/a n/a
Payout Ratio
n/a n/a
Gross Profit Margin
1.00 1.00
Net Profit Margin
-0.62 -3.38
Pretax Profit Margin
-0.62 -3.38
Operating Profit Margin
-0.64 -3.38
FCF Margin
n/a n/a
EBITDA Margin
-0.61 -3.38